Semaglutide
STEP 5
Novo Nordisk · Phase 3 · Completed · Enrollment 304
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
| Semaglutide 2.4 mg, in trial | 81 participants | 46 participants | 53 participants | n/r | 1 |
| Placebo, in trial | 33 participants | 7 participants | 36 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.